FDA Extends Comment Period On Generic Drugs Rule
The agency is now accepting public input on the proposed rule through March 13, in response to requests for more time from stakeholders. The deadline for the Nov. 8 proposal originally was Jan. 13.
The proposed change would eliminate prohibitions preventing generics makers from revising safety information until the brand-name counterpart has...
To view the full article, register now.